Aberrant ROCK activation promotes the development of type I diabetes in NOD mice.

[1]  G. Bhagat,et al.  Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. , 2010, The Journal of clinical investigation.

[2]  J. Ilonen,et al.  IL-17 Immunity in Human Type 1 Diabetes , 2010, The Journal of Immunology.

[3]  G. Bhagat,et al.  IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? , 2010, Immunological reviews.

[4]  A. Shapiro,et al.  Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice , 2009, Diabetes.

[5]  M. Michaud,et al.  Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice , 2009, Diabetes.

[6]  Yi-hong Wang,et al.  Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells , 2009, European journal of immunology.

[7]  A. Hafezi-Moghadam,et al.  Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage , 2009, Diabetes.

[8]  M. Huber,et al.  IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype , 2008, Proceedings of the National Academy of Sciences.

[9]  G. Bhagat,et al.  IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. , 2008, Immunity.

[10]  W. Leonard,et al.  IL-21 signaling is critical for the development of type I diabetes in the NOD mouse , 2008, Proceedings of the National Academy of Sciences.

[11]  N. Sarvetnick,et al.  IL-21 Limits Peripheral Lymphocyte Numbers through T Cell Homeostatic Mechanisms , 2008, PloS one.

[12]  K. Chorneyko,et al.  RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease , 2008, Diabetes.

[13]  Hui Peng,et al.  Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control , 2008, Diabetes.

[14]  J. Ellis,et al.  Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production , 2008, The Journal of experimental medicine.

[15]  Oliver S Burren,et al.  Gene-gene interactions in the NOD mouse model of type 1 diabetes. , 2008, Advances in immunology.

[16]  R. Tisch,et al.  Dysrulation of T cell peripheral tolerance in type 1 diabetes. , 2008, Advances in immunology.

[17]  J. Liao,et al.  A method for measuring Rho kinase activity in tissues and cells. , 2008, Methods in enzymology.

[18]  T. Mak,et al.  The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 , 2007, Nature Immunology.

[19]  N. Tajima,et al.  The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. , 2007, European journal of pharmacology.

[20]  J. Liao,et al.  Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.

[21]  Y. Kikuchi,et al.  A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. , 2007, The Journal of endocrinology.

[22]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[23]  A. Takeshita,et al.  Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice , 2004, Circulation.

[24]  N. Sarvetnick,et al.  Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.